FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/05/033681 [Registered on: 18/05/2021] Trial Registered Prospectively
Last Modified On: 09/04/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative study of Chitraktriphladi Kashayam with madhu and Chitraktriphladi Kashayam Ghana vati in Diabetes. 
Scientific Title of Study   “A Randomized Clinical Comparative Study on Chitraktriphaladi Kashayam with Madhu and Chitraktriphaladi Kashayam Ghana Vati in the Management Of Madhumeha Type-2 Diabetes Mellitus.” 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Parveen Sharma 
Designation  PG Scholar 
Affiliation  National Institute of Ayurveda, Jaipur 
Address  P.G. Department of Kayachikitsa National Institute of Ayurveda,Jaipur-302002
National Institute of Ayurveda , Madhav Vilas, Amer Road, ,Jaipur-302002
Jaipur
RAJASTHAN
302002
India 
Phone  9068000101  
Fax    
Email  drparveensharma44@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajay Kumar Sahu 
Designation  Associate Professor 
Affiliation  National Institute of Ayurveda 
Address  P.G. Department of Kayachikitsa National Institute of Ayurveda,Jaipur-302002
National Institute of Ayurveda , Madhav Vilas, Amer Road, ,Jaipur-302002
Jaipur
RAJASTHAN
302002
India 
Phone  9950708106  
Fax    
Email  drajaysahu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Parveen Sharma 
Designation  PG Scholar 
Affiliation  National Institute of Ayurveda 
Address  P.G. Department of Kayachikitsa National Institute of Ayurveda,Jaipur-302002
National Institute of Ayurveda , Madhav Vilas, Amer Road, ,Jaipur-302002
Jaipur
RAJASTHAN
302002
India 
Phone  9068000101  
Fax    
Email  drparveensharma44@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda, Jaipur( 302002 ) 
 
Primary Sponsor  
Name  National Institute of Ayurveda Jaipur 
Address  Jorawar Singh Gate, Amer Road, Jaipur , 332002 ( Rajasthan ) 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parveen Sharma  National Institute of Ayurveda and Hospital  OPD No 1,7,18,22,25, Arogyasala , PG Department of Kayachikitsa, NIA, Jorawar Singh Gate, Amer Road, Jaipur 302002 ( Rajasthan )
Jaipur
RAJASTHAN 
9068000101

drparveensharma44@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee National Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Chitraktriphaladi Kashayam Ghana Vati  Orally, Twice a day before meal for 30 days with luke warm water ( Dosage will be decided as per extract obtained from kwatha) 
Intervention  Chitraktriphaladi Kashayam With Madhu  Orally , 40 ml BD before meal for 30 days  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients giving the clinical history of DM (Type II).
2. Patients having hyperglycaemia confirmed by laboratory investigations i.e. Fasting
Blood Sugar (FBS) ≥ 126mg/dl or Post Prandial Blood Sugar (PPBS) ≥ 140-300 mg/dl
3. Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydypsia, polyphagia).
 
 
ExclusionCriteria 
Details  i. Patients below 30 years of age & above 70 years of age.
ii. Patients having Type I DM.
iii. Patients of Type II DM who are on insulin therapy.
iv. Patients having any serious illness like Coronary Artery Disease, malignancy, hypertension > 140/90 mm of Hg etc.
v. Drug induced DM.
vi. F.B.S. > 200 mg/dl and P.P.B.S. > 300 mg/dl.
vii. Patients having chronicity of more than 5 years.
viii. DM with complications.
ix. Pregnant and lactating mother
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in Cardinal Symptoms of Type -II Diabetes Mellitus ( Madhumeha )  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in the objective parameters.  30 Days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIMS & OBJECTIVES:

1.      To assess clinical efficacy of Chitraktriphladi Kashayam with Madhu in the management of a series of patients suffering from Madhumeha (DM Type II).

2.      To assess clinical efficacy of Chitraktriphladi Kashayam Ghana Vati in the management of a series of patients suffering from Madhumeha (DM Type II).

To compare the efficacy of Chitraktriphaladi Kashayam with Madhu and Chitraktriphaladi Kashayam Ghana Vati in the management of Madhumeha (DM Type II).


HYPOTHESIS

 

Null hypothesis [H0]:

 

Chitraktriphaladi Kashayam with Madhu and Chitraktriphaladi Kashayam Ghana Vati are equally effective in the Management Of Madhumeha (Type-2 Diabetes Mellitus).”

 

   MATERIALS & METHODS

 

Following materials and methods will be employed for conducting the present research    work-

CLINICAL STUDY

Following materials and methods will be employed for conducting the present research work-

 Selection of Cases:

 

§  The study will be conducted in 30 clinically diagnosed and confirmed patients of Madhumeha (Type II Diabetes Mellitus) from OPD/IPD of NIA hospital, Jaipur. These patients will be randomly divided into two groups - Group A, Group B with 15

patients in each group.

Diagnostic Criteria

 

§  Diagnosis based on presenting clinical features of Madhumeha (Type II DM).

 

§  Subjects with FBS > 126 mg/dl, PPBS > 140-300 mg/ dl

Study Design:

The present study is supposed to be-

·         Level of study                        : OPD/IPD

·         Study type                              : Interventional, Single Centre

·         Purpose                                  : Treatment

·         Masking                                 : Open Label

·         Timing                                    : Prospective

·         End point                               : Safety and efficacy

·         No. of groups                          : Two (15 patients in each group)

No. of patients            30

·         Duration of Study                  : 30 days

·         Follow-up                               : 15th day, 30th day after initial assessment.


 
Close